I could certainly see someone make that argument. I have no qualifications to offer medical advice. I am qualified to analyze the cost benefit if given sufficient data. I don't believe there is sufficient data on most aspects of this decision to perform a solid analysis unfortunately.
Typically flu seasonal deaths are higher one year, lower the next, then higher, etc. Likely due to immune boosting from the prior year, and death of the most susceptible. Measles had a 3-4 year cycle like this, with low prevalence while the pool of susceptible young kids increased.
So two years of high excess deaths is highly unusual, if due just to the SARS-Cov-2 virus.
I wonder if the excess deaths in both years are due to the virus spike protein: from infection in 2020, from the vaccines in 2021. Any ideas about how to confirm or refute this?
Would you say this is an argument for boosters, then?
I could certainly see someone make that argument. I have no qualifications to offer medical advice. I am qualified to analyze the cost benefit if given sufficient data. I don't believe there is sufficient data on most aspects of this decision to perform a solid analysis unfortunately.
Typically flu seasonal deaths are higher one year, lower the next, then higher, etc. Likely due to immune boosting from the prior year, and death of the most susceptible. Measles had a 3-4 year cycle like this, with low prevalence while the pool of susceptible young kids increased.
So two years of high excess deaths is highly unusual, if due just to the SARS-Cov-2 virus.
I wonder if the excess deaths in both years are due to the virus spike protein: from infection in 2020, from the vaccines in 2021. Any ideas about how to confirm or refute this?
Excellent! :-)